These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2656930)

  • 1. Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Feb; 1(1):35-8. PubMed ID: 2656930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults.
    Melcher GP; Hadfield TL; Gaines JK; Winn RE
    J Antimicrob Chemother; 1988 Oct; 22(4):549-56. PubMed ID: 3060461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
    Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin tolerance and erythromycin resistance of group A beta-hemolytic streptococci in Hawaii and the Philippines.
    Wittler RR; Yamada SM; Bass JW; Hamill R; Wiebe RA; Ascher DP
    Am J Dis Child; 1990 May; 144(5):587-9. PubMed ID: 2184661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis.
    Ruggiero G; Utili R; Adinolfi LE; Attanasio V; Scarano MP; Mazzone A; Costa G; Califano L; Costa F
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():103-9. PubMed ID: 8478300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of group A beta-hemolytic streptococci resistant to erythromycin in Athens, Greece.
    Stamos G; Bedevis K; Paraskaki I; Chronopoulou A; Tsirepa M; Foustoukou M
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):70-1. PubMed ID: 11245331
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to erythromycin in group A streptococci.
    Seppälä H; Nissinen A; Järvinen H; Huovinen S; Henriksson T; Herva E; Holm SE; Jahkola M; Katila ML; Klaukka T
    N Engl J Med; 1992 Jan; 326(5):292-7. PubMed ID: 1728733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.
    Maruyama S; Yoshioka H; Fujita K; Takimoto M; Satake Y
    Am J Dis Child; 1979 Nov; 133(11):1143-5. PubMed ID: 389035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benzathine penicillin G and miocamycin in the treatment of children with streptococcal pharyngitis: a controlled therapeutic trial].
    Lagos R; Topelberg S; Herrera P; Dattas JP; Vallejos M; Aguilera A L
    Rev Med Chil; 1993 Nov; 121(11):1274-9. PubMed ID: 8191134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.
    Istre GR; Welch DF; Marks MI; Moyer N
    Antimicrob Agents Chemother; 1981 Aug; 20(2):244-6. PubMed ID: 7025754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.